Navigation Links
Altheus Therapeutics Completes Phase I Clinical Study of Zoenasa™ in Ulcerative Colitis
Date:1/6/2011

OKLAHOMA CITY, Jan. 6, 2011 /PRNewswire/ -- Altheus Therapeutics, Inc., announced that it has completed a two dose, double-blind, active-controlled Phase I clinical trial of the safety and tolerability of Zoenasa™ Rectal Suspension in adult patients with left-sided, or distal, ulcerative colitis.  No serious adverse events were experienced by patients in this study.  "We are excited to have achieved this milestone, as it prepares Altheus to begin our planned Phase II clinical program to definitively evaluate the safety and efficacy of Zoenasa in ulcerative colitis patients," commented Dennis Schafer, President and CEO of Altheus.

Nearly 1.2 million Americans suffer from inflammatory bowel disease. The two most common forms, ulcerative colitis and Crohn's disease, are chronic lifelong conditions which significantly impact the quality of life. Front-line treatment for ulcerative colitis is monotherapy with oral or rectal mesalamine.  However many patients do not achieve remission and must escalate to more expensive and risky treatments.

Zoenasa is a novel combination of two FDA-approved drugs with well established efficacy and safety records that have been shown to act synergistically for the treatment of ulcerative colitis.  In animal models of colitis, Zoenasa resolved inflammation more rapidly and completely than standard mesalamine treatment.  Zoenasa Rectal Suspension is being investigated for the treatment of left-sided ulcerative colitis, which affects approximately 80% of ulcerative colitis patients.  The U.S. Food and Drug Administration has granted Zoenasa orphan designation for the treatment of pediatric ulcerative colitis.  An oral formulation of Zoenasa is in pre-clinical development.

Altheus Therapeutics, Inc., of Oklahoma City, is a pharmaceutical development company focused on innovative therapies for the treatment of inflammatory bowel disease. Contact:Dennis Schafer, CEO

SOURCE Altheus Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... ALISO VIEJO , Kalifornien, 20. Mai ... heute bekannt, dass das Unternehmen die CE-Kennzeichnung ... Implantate zur Embolisation von Aneurysmen erhalten hat. ... in Europa bereits mit der kontrollierten Einführung ... Profil bietet die SL-Produktfamilie auch ein verbessertes ...
(Date:5/20/2013)... Hyland Software expands upon its extensive ... Multi-Disciplinary Clinical Leadership Team. Led by nurses and ... diverse healthcare experience, the team will leverage its ... software solutions that will enhance the clinical experience ... staff. Healthcare organizations use OnBase, Hyland ...
(Date:5/20/2013)... , May 20, 2013  TNI BioTech, Inc. ... the activation and mobilization of the body,s immune system using ... the OTC Markets, OTCQB marketplace under the ticker symbol ... view the real-time Level II stock quotes for TNIB ... Griffin , CEO of TNI BioTech, Inc. stated, ...
Breaking Medicine Technology:Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 2Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 3Hyland Software Forms Multi-Disciplinary Clinical Leadership Team to Augment Healthcare Solutions 2TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace 2TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace 3
... Sigma-Aldrich Corporation (NASDAQ: SIAL ) will ... KeyBanc Capital Markets 2011 Basic Materials ... InterContinental, Boston, MA, presenting at 9:00 AM (Eastern). ... at the Grand Hyatt, New York, NY, presenting at ...
... SimonMed and Cox Business have partnered to make a ... patients in the Valley and across the state at ... is the first dedicated outpatient offering of breast tomosynthesis ... in Scottsdale. Sub-specialty trained radiologists at SimonMed ...
Cached Medicine Technology:Sigma-Aldrich Corporation to Present at Upcoming Investor Conferences 2SimonMed and Cox Business Bring Breast Tomosynthesis to Arizona 2
(Date:5/21/2013)... May 21, 2013 The National ... announce four transitions for its Board of Directors. ... Western Michigan University School of Medicine, has been named ... Education at the University of California San Diego, is ... Officer of the Nebraska Medical Center, is the Secretary-Treasurer. ...
(Date:5/21/2013)... The Michigan Lupus Foundation will be ... , June 11th. , Meeting Details: , Tuesday, June ... Center,     Conference Room 5 (Lower Level),     1375 North Main ... to assist people with lupus and their family and ... get a better understanding of this disease and how ...
(Date:5/21/2013)... 21, 2013 The birth control safety ... who have used the contraceptive NuvaRing. A new report ... clot injuries has increased in recent months*. , DrugRisk ... and devices with the latest safety alerts, recalls, studies ... are experiencing similar side effects and decide if they ...
(Date:5/20/2013)... USA Book News announced Monday that "The ... won the top honor in its 2013 International Book ... multitude of international titles published from 2011-2013, "The Infinity ... both mainstream and new age audiences looking to improve ... , “The Infinity Zone” is a phenomenon ...
(Date:5/20/2013)... The automated external defibrillator market ... categories - semi-automated and fully automated defibrillators. Based ... categories, namely, hospitals, pre-hospital, public access, alternate care, ... Automated external defibrillators play an important role in ... Considering the life-saving potential of AEDs, legislations requiring ...
Breaking Medicine News(10 mins):Health News:New Board of Directors Leadership for The Match- National Resident Matching Program® 2Health News:New Board of Directors Leadership for The Match- National Resident Matching Program® 3Health News:DrugRisk Update Shows Increase in NuvaRing Blood Clot Lawsuits 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 3Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 2Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 3
... nervous system, triggering the movement disorder, researchers say, , , MONDAY, ... being obese appears to increase the risk for restless legs ... to 10 percent of adults in the United States have ... compelling need to move their legs, especially when they,re lying ...
... million for children,s hospitals nationwide, including approximately $400,000 for Children,s ... Union Cherry Blossom Ten Mile Run. , ... ... raised $1 million for children,s hospitals nationwide, including approximately $400,000 ...
... of Avastin alone to treat a subgroup of recurrent ... effective at delaying tumor progression, according to a retrospective ... the Seattle Cancer Care Alliance., The patients all had ... (AO), for which there is no existing standard therapy. ...
... in TreatmentCOLUMBIA, S.C., April 6 Companion ... Honors for Health Plans and Health Networks by leading ... The honor was announced at the 2009 ... Awards Gala on April 1-2 in Orlando, ...
... respected and renowned Smoking Cessation Specialist Franc Tausch achieves record success ... one session , ... Los Angeles, CA (PRWEB) August ... Los Angeles, California enables smokers to stop smoking for ...
... to Offer Contributions, Goods, and Assistance as Scores Die and ... The catastrophic earthquake in Italy this morning that has left ... homeless is a subject of grave concern and sadness for ... "Like all Americans, the members of our foundation, who ...
Cached Medicine News:Health News:Pot Belly Boosts Risk for Restless Legs Syndrome 2Health News:Credit Union Cherry Blossom Ten Mile Run Cherry Blossom Ten-Miler Raises $400,000 For Children's National Medical Center 2Health News:Avastin effective at delaying brain tumor progression in recurrent disease 2Health News:Companion Benefit Alternatives Awarded Silver Honors for Best Practices in Health Plans and Health Networks by URAC 2Health News:Companion Benefit Alternatives Awarded Silver Honors for Best Practices in Health Plans and Health Networks by URAC 3Health News:Hypnotherapy Breakthrough: Renowned Smoking Cessation Specialist Helps To Stop Smoking In One Session 2
Utrata-like fine angled tips with gently curved shaft for performing capsulorhexis through tunnel incisions. Dull finish. Round handle manufactured in titanium....
Fine angled tips ideal for grasping delicate capsule. Angled 12 mm shafts with iris stop allows ease of movement in the anterior chamber. Flat handle with dull finish. Manufactured in titanium....
Titanium forceps with gently curved jaws and ultra fine sharpened tips for puncture and grasping the capsule. Round handle is excellent for precise finger-tip control...
Regular tip. 1 mm x 13 mm. Serrated. Insulated....
Medicine Products: